Airan Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 15, 2025, 7:59 pm

Quick Insight

Airan Ltd, an IT Enabled Services company, currently trades at ₹25.5 with a market capitalization of ₹319 Cr. The company boasts a healthy Return on Equity (ROE) of 13.6% and Return on Capital Employed (ROCE) of 16.3%, indicating efficient utilization of capital. With a Price-to-Earnings (P/E) ratio not provided, investors might find it challenging to gauge the stock's valuation. However, the company's Operating Profit Margin (OPM) stands at a respectable 15.18%, reflecting operational efficiency. Airan Ltd's Interest Coverage Ratio (ICR) of 73.73x signals a comfortable ability to service debt obligations.

On the positive side, Airan Ltd's strong promoter holding of 72.34% provides stability and aligns interests with shareholders. The company's low level of borrowings at ₹2 Cr and healthy reserves of ₹119 Cr offer a robust financial position. However, the absence of Foreign Institutional Investors (FIIs) and negligible Domestic Institutional Investors (DIIs) ownership could raise concerns about limited institutional interest. Looking ahead, Airan Ltd could enhance investor confidence by improving transparency through detailed financial disclosures and diversifying its shareholder base to reduce concentration risk.

In the context of India's evolving IT services sector, where technological advancements and digital transformation are driving growth, Airan Ltd's financial metrics position it reasonably well. Comparing these figures with industry peers or sector averages would provide a clearer picture of the company's performance relative to its competitors. Indian investors should closely monitor any regulatory changes impacting the IT sector and keep an eye on macroeconomic indicators that could influence Airan Ltd's future prospects. In conclusion, while Airan Ltd exhibits strengths in financial stability and operational efficiency, diversification of its investor base and enhanced transparency could further bolster its position in the market.

Competitors of Airan Ltd

All Competitor Stocks of Airan Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:10 pm

Below is a detailed analysis of the quarterly data for Airan Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 25.70 Cr.. The value appears to be declining and may need further review. It has decreased from 27.31 Cr. (Mar 2025) to 25.70 Cr., marking a decrease of 1.61 Cr..
• For Expenses, as of Jun 2025, the value is 21.80 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 22.73 Cr. (Mar 2025) to 21.80 Cr., marking a decrease of 0.93 Cr..
• For Operating Profit, as of Jun 2025, the value is 3.90 Cr.. The value appears to be declining and may need further review. It has decreased from 4.58 Cr. (Mar 2025) to 3.90 Cr., marking a decrease of 0.68 Cr..
• For OPM %, as of Jun 2025, the value is 15.18%. The value appears to be declining and may need further review. It has decreased from 16.77% (Mar 2025) to 15.18%, marking a decrease of 1.59%.
• For Other Income, as of Jun 2025, the value is 1.61 Cr.. The value appears strong and on an upward trend. It has increased from -6.59 Cr. (Mar 2025) to 1.61 Cr., marking an increase of 8.20 Cr..
• For Interest, as of Jun 2025, the value is 0.04 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.08 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 0.04 Cr..
• For Depreciation, as of Jun 2025, the value is 1.26 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.16 Cr. (Mar 2025) to 1.26 Cr., marking an increase of 0.10 Cr..
• For Profit before tax, as of Jun 2025, the value is 4.21 Cr.. The value appears strong and on an upward trend. It has increased from -3.25 Cr. (Mar 2025) to 4.21 Cr., marking an increase of 7.46 Cr..
• For Tax %, as of Jun 2025, the value is 23.04%. The value appears to be increasing, which may not be favorable. It has increased from 5.54% (Mar 2025) to 23.04%, marking an increase of 17.50%.
• For Net Profit, as of Jun 2025, the value is 3.23 Cr.. The value appears strong and on an upward trend. It has increased from -3.44 Cr. (Mar 2025) to 3.23 Cr., marking an increase of 6.67 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.25. The value appears strong and on an upward trend. It has increased from -0.28 (Mar 2025) to 0.25, marking an increase of 0.53.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 5:19 pm

Growth

Last Updated: September 4, 2025, 10:30 pm

Balance Sheet

Last Updated: June 16, 2025, 12:32 pm

Below is a detailed analysis of the balance sheet data for Airan Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 25.00 Cr..
• For Reserves, as of Mar 2025, the value is 119.00 Cr.. The value appears strong and on an upward trend. It has increased from 101.00 Cr. (Mar 2024) to 119.00 Cr., marking an increase of 18.00 Cr..
• For Borrowings, as of Mar 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1.00 Cr. (Mar 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 32.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 31.00 Cr. (Mar 2024) to 32.00 Cr., marking an increase of 1.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 179.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 158.00 Cr. (Mar 2024) to 179.00 Cr., marking an increase of 21.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 81.00 Cr.. The value appears to be declining and may need further review. It has decreased from 82.00 Cr. (Mar 2024) to 81.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
• For Investments, as of Mar 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 15.00 Cr., marking an increase of 7.00 Cr..
• For Other Assets, as of Mar 2025, the value is 81.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Mar 2024) to 81.00 Cr., marking an increase of 14.00 Cr..
• For Total Assets, as of Mar 2025, the value is 179.00 Cr.. The value appears strong and on an upward trend. It has increased from 158.00 Cr. (Mar 2024) to 179.00 Cr., marking an increase of 21.00 Cr..

Notably, the Reserves (119.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Airan Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 0.98. This value is below the healthy minimum of 5. It has increased from 0.81 (Mar 23) to 0.98, marking an increase of 0.17.
• For Diluted EPS (Rs.), as of Mar 24, the value is 0.98. This value is below the healthy minimum of 5. It has increased from 0.81 (Mar 23) to 0.98, marking an increase of 0.17.
• For Cash EPS (Rs.), as of Mar 24, the value is 1.47. This value is below the healthy minimum of 3. It has increased from 1.27 (Mar 23) to 1.47, marking an increase of 0.20.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 10.08. It has increased from 9.10 (Mar 23) to 10.08, marking an increase of 0.98.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 10.08. It has increased from 9.10 (Mar 23) to 10.08, marking an increase of 0.98.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 8.44. It has increased from 7.79 (Mar 23) to 8.44, marking an increase of 0.65.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 1.81. This value is below the healthy minimum of 2. It has increased from 1.57 (Mar 23) to 1.81, marking an increase of 0.24.
• For PBIT / Share (Rs.), as of Mar 24, the value is 1.37. This value is within the healthy range. It has increased from 1.15 (Mar 23) to 1.37, marking an increase of 0.22.
• For PBT / Share (Rs.), as of Mar 24, the value is 1.35. This value is within the healthy range. It has increased from 1.11 (Mar 23) to 1.35, marking an increase of 0.24.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 1.03. This value is below the healthy minimum of 2. It has increased from 0.85 (Mar 23) to 1.03, marking an increase of 0.18.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 1.00. This value is below the healthy minimum of 2. It has increased from 0.82 (Mar 23) to 1.00, marking an increase of 0.18.
• For PBDIT Margin (%), as of Mar 24, the value is 21.45. This value is within the healthy range. It has increased from 20.10 (Mar 23) to 21.45, marking an increase of 1.35.
• For PBIT Margin (%), as of Mar 24, the value is 16.28. This value is within the healthy range. It has increased from 14.82 (Mar 23) to 16.28, marking an increase of 1.46.
• For PBT Margin (%), as of Mar 24, the value is 15.99. This value is within the healthy range. It has increased from 14.19 (Mar 23) to 15.99, marking an increase of 1.80.
• For Net Profit Margin (%), as of Mar 24, the value is 12.21. This value exceeds the healthy maximum of 10. It has increased from 11.01 (Mar 23) to 12.21, marking an increase of 1.20.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 11.89. This value is within the healthy range. It has increased from 10.63 (Mar 23) to 11.89, marking an increase of 1.26.
• For Return on Networth / Equity (%), as of Mar 24, the value is 9.95. This value is below the healthy minimum of 15. It has increased from 9.10 (Mar 23) to 9.95, marking an increase of 0.85.
• For Return on Capital Employeed (%), as of Mar 24, the value is 12.06. This value is within the healthy range. It has increased from 10.98 (Mar 23) to 12.06, marking an increase of 1.08.
• For Return On Assets (%), as of Mar 24, the value is 7.92. This value is within the healthy range. It has increased from 7.01 (Mar 23) to 7.92, marking an increase of 0.91.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 23) to 0.00, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.01. This value is within the healthy range. It has decreased from 0.04 (Mar 23) to 0.01, marking a decrease of 0.03.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.68. There is no change compared to the previous period (Mar 23) which recorded 0.68.
• For Current Ratio (X), as of Mar 24, the value is 4.73. This value exceeds the healthy maximum of 3. It has increased from 4.27 (Mar 23) to 4.73, marking an increase of 0.46.
• For Quick Ratio (X), as of Mar 24, the value is 4.73. This value exceeds the healthy maximum of 2. It has increased from 4.27 (Mar 23) to 4.73, marking an increase of 0.46.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 73.73. This value is within the healthy range. It has increased from 31.91 (Mar 23) to 73.73, marking an increase of 41.82.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 42.99. This value is within the healthy range. It has increased from 18.49 (Mar 23) to 42.99, marking an increase of 24.50.
• For Enterprise Value (Cr.), as of Mar 24, the value is 287.80. It has increased from 168.45 (Mar 23) to 287.80, marking an increase of 119.35.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.73. This value is within the healthy range. It has increased from 1.73 (Mar 23) to 2.73, marking an increase of 1.00.
• For EV / EBITDA (X), as of Mar 24, the value is 12.71. This value is within the healthy range. It has increased from 8.60 (Mar 23) to 12.71, marking an increase of 4.11.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.71. This value is within the healthy range. It has increased from 1.79 (Mar 23) to 2.71, marking an increase of 0.92.
• For Price / BV (X), as of Mar 24, the value is 2.27. This value is within the healthy range. It has increased from 1.53 (Mar 23) to 2.27, marking an increase of 0.74.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.71. This value is within the healthy range. It has increased from 1.79 (Mar 23) to 2.71, marking an increase of 0.92.
• For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 23) to 0.04, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness